Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 5,681–5,700 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytotoxic Agent, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, NDC 72606-558-01.

by Shilpa Medicare Limited

Reason
CGMP Deviations
Recall initiated
December 8, 2020
Reported by FDA
December 16, 2020
Distribution
Nationwide in the U.S.

View recall →

Drug Recall Terminated Historical recordClass II

Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single Dose Vial, Cytotoxic Agent, Manufactured by: Shilpa Medicare Limited, Jadcherla, 509301, India, Distributed by: Armas Pharmaceuticals, Inc. Manalapan, NJ 07726 NDC 72485-201-01.

by Shilpa Medicare Limited

Reason
CGMP Deviations
Recall initiated
December 8, 2020
Reported by FDA
December 16, 2020
Distribution
Nationwide in the U.S.

View recall →

Drug Recall Terminated Historical recordClass II

Busulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only, Must be diluted before use, Single Dose Vial, Sterile, Cytotoxic Agent, Rx Only, 10 mL vial, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, Vial NDC 72485-210-01, Carton NDC 72485-210-08.

by Shilpa Medicare Limited

Reason
CGMP Deviations
Recall initiated
December 8, 2020
Reported by FDA
December 16, 2020
Distribution
Nationwide in the U.S.

View recall →

Drug Recall Terminated Historical recordClass I

Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL Single Dose Bottle, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-671-05

by Fresenius Kabi USA, LLC

Reason
Cross Contamination with other products: trace amounts of lidocaine
Recall initiated
November 17, 2020
Reported by FDA
December 16, 2020
Distribution
USA Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Protz real protection Antibacterial Hand Sanitizer, Ethyl Alcohol 70%, 13.5 FL OZ (400 mL), Distributed by: Safety-Med Products, Inc. Burlington, WI 53105 Made in Mexico by Asiaticon S.A. de C.V. Conkal No. 62, Mexico, Ciudad de Mexico 14200, Mexico NDC: 75192-600-02 UPC 7 503019 005002

by Asiaticon, SA de CV

Reason
Lack of CGMPs:
Recall initiated
August 25, 2020
Reported by FDA
December 16, 2020
Distribution
Distributed in Texas

View recall →

Drug Recall Terminated Historical recordClass II

V-Klean Hand Sanitizer Gel Alcohol 70% packaged as a)8.5 fl oz (250 ml), UPC 7 16053 70499 3; b) 16.9 fl oz (500 ml), UPC 7 16053 70499 3; c) 33.8 fl. oz. (1000 ml) bottles: 716053704993; Manufactured by: Asiaticon S.A. de C.V. Conkar 62, Jardines del Ajusco. Tlalpan Cuidad de Mexico. 14200 ;

by Asiaticon, SA de CV

Reason
Lack of CGMPs:
Recall initiated
August 25, 2020
Reported by FDA
December 16, 2020
Distribution
Distributed in Texas

View recall →

Drug Recall Terminated Historical recordClass II

Tizanidine Tablets, USP 4mg, Rx Only, 150 Tablets per Bottle, Manufactured by Alkem Laboratories Ltd, Mumbai - 400 013, INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC: 67877-614-15.

by Ascend Laboratories LLC

Reason
Failed Dissolution Specifications; Out of Specification (low) results were obtained.
Recall initiated
November 24, 2020
Reported by FDA
December 9, 2020
Distribution
MI

View recall →

Drug Recall Terminated Historical recordClass I

Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01

by Torrent Pharma Inc

Reason
Failed Dissolution Specifications
Recall initiated
November 25, 2020
Reported by FDA
December 9, 2020
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass III

Clobetasol Propionate Ointment USP 0.05%, Net Wt. 50 grams, Rx Only, Teligent Pharma. Inc. Buena, NJ 08310 NDC 52565-039-60

by Teligent Pharma, Inc.

Reason
Superpotent and Subpotent; low and high assay results
Recall initiated
November 5, 2020
Reported by FDA
December 9, 2020
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

REGENECARE HA (Lidocaine HCL 2%) Topical Anesthetic Hydrogel, Net Wt. 3 oz. (85 g), Manufactured For: MPM Medical Mesquite, TX 75149. NDC 66977-107-03

by MPM Medical LLC

Reason
Microbial Contamination of Non-Sterile Drug Product. The product was found to be contaminated with the bacteria Burkholderia cepecia.
Recall initiated
November 17, 2020
Reported by FDA
December 9, 2020
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass III

Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc. New Castle, DE 19720. NDC 10135-0639-30

by InvaTech Pharma Solutions, LLC

Reason
Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing.
Recall initiated
November 11, 2020
Reported by FDA
December 9, 2020
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Aripiprazole Tablets, USP, 15 mg, 30 tablets per unit dose carton, Rx Only, Manufactured by: Apotex, Inc, Toronto, Ontario Canada M9L 1T9, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6512-04

by The Harvard Drug Group

Reason
Failed Dissolution Specifications: Out of specification for dissolution.
Recall initiated
November 18, 2020
Reported by FDA
December 9, 2020
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

CVS Health Hydrating Healing Ointment (Petrolatum 41%), Net Wt 3 OZ (85g), Distributed by CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895 UPC 0 50428 53642 1

by US Pharmaceuticals Inc.

Reason
Lack Of CGMP:s Low weight fill tubes were identified in one lot of CVS Healing Ointment.
Recall initiated
November 19, 2020
Reported by FDA
December 9, 2020
Distribution
Distributed in RI

View recall →

Drug Recall Terminated Historical recordClass II

ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc. Toronto, Ontario, Canada, Packaged by GSMS, Incorporated, Camarillo, CA 93012 USA, NDC #60429-449-30

by Golden State Medical Supply Inc.

Reason
FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets
Recall initiated
November 17, 2020
Reported by FDA
December 9, 2020
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass I

Chlorhexidine Gluconate Oral Rinse USP, 0.12%, Alcohol Free, packaged in 15 mL unit does cups (barcode 7016602715), packaged in 50-count unit dose cups per carton, Rx only, Distributed by: Lohxa, Worcester, MA 01608, NDC 70166-027-15

by Lohxa LLC

Reason
Microbial contamination of non-sterile products: Repackaged product was recalled by manufacturer because it was contaminated with the bacteria Burkholderia lata.
Recall initiated
October 28, 2020
Reported by FDA
December 9, 2020
Distribution
Product was distributed to medical facilities in FL and NY.

View recall →

Drug Recall Terminated Historical recordClass III

Triamcinolone Acetonide Lotion USP, 0.025%, 60 mL (60 grams) bottle, Rx Only, Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-010-59

by Teligent Pharma, Inc.

Reason
Subpotent Drug: One lot of Triamcinolone Acetonide Lotion, 0.025% 60 mL.does not meet assay results.
Recall initiated
November 3, 2020
Reported by FDA
December 2, 2020
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Levetiracetam Tablets, USP 500 mg, packaged in 120-count bottle, Rx only, Manufactured by: VKT Pharma Private Limited Srikakulam, India - 532 409, Manufactured for: Eywa Pharma Inc. 2 Research Way, Floor 3 Princeton, NJ 08540, NDC 71930-063-52

by EYWA PHARMA INC

Reason
Presence of foreign tablet/capsule: A 1000 mg Levetiracetam Tablet was found in 500 gram bottle of Levetiracetam Tablets.
Recall initiated
November 10, 2020
Reported by FDA
December 2, 2020
Distribution
USA Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: Heritage Pharmaceuticals Inc. East Brunswick, NJ 08816 Made in India, NDC 23155-050-01

by Heritage Pharmaceuticals Inc

Reason
Failed impurities/ degradation specifications: Out of specification impurity results were observed during routine testing of stability samples for the impurity Felodipine Related compound A
Recall initiated
October 23, 2020
Reported by FDA
December 2, 2020
Distribution
USA Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Immune Boost with natural strawberry flavor, 8,000 IU, Supports a Healthy and Balanced Immune System, 60 mL bottle, Manufactured by: Fusion Health and Vitality, LLC. 1360 Union Hill Road, Suite 11B Alpharetta, GA 30004.

by Fusion Health and Vitality LLC

Reason
Marketed without an Approved NDA/ANDA: Product marketed with drug claims.
Recall initiated
November 18, 2020
Reported by FDA
December 2, 2020
Distribution
Nationwide in the U.S.

View recall →

Drug Recall Terminated Historical recordClass III

DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047. NDC: 63323-883-05

by Fresenius Kabi USA, LLC

Reason
Cross Contamination with Other Products: trace amounts of octreotide found during testing
Recall initiated
November 17, 2020
Reported by FDA
December 2, 2020
Distribution
Nationwide USA and Puerto Rico

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.